Watch Ticker

Gyre Therapeutics, Inc. Common Stock

Go to Gyre Therapeutics, Inc. Common Stock Website

$6.92

-0.10 (-1.42%)

Live

Previous Close

$7.02

Day Range

$6.81 - $7.09

Previous Day Range

$6.71 - $7.11

Market Cap

$602.9 million USD

Day Vol.

58353

Previous Day Vol.

76581

Currency

USD

Primary Exchange

None

Gyre Therapeutics Inc is a commercial-stage pharmaceutical company developing and commercializing small-molecule anti-inflammatory and anti-fibrotic drugs targeting organ diseases, focusing specifically on organ fibrosis. The company's commercial-sta...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Gyre Therapeutics Announces First Dosing in Phase 1 Trial of F230 for Pulmonary Arterial Hypertension in China

Gyre Therapeutics announced the first dosing in a Phase 1 clinical trial of its novel drug F230 for the treatment of pulmonary arterial hypertension (PAH) in China. This milestone marks Gyre's entry into the PAH field, a rare and high-mortality condition with limited treatment options.

Related tickers: GYRE.

Read Full Article

N/A - Gyre Therapeutics Announces Pricing of $20.0 Million Public Offering of Common Stock

Gyre Therapeutics, a biotechnology company, announced the pricing of its public offering of 2,222,222 shares of common stock at $9.00 per share, with an option for underwriters to purchase an additional 333,333 shares. The company plans to use the net proceeds to advance its clinical trial and for general corporate purposes.

Related tickers: GYRE.

Read Full Article

Trending Tickers

Please sign in to view